Lansoprazole Current Events | Lansoprazole News
|
|
|
Sort By:
Page Views | Date |
Chronic diarrhea unresponsive to conventional medication: Are you taking lansoprazole?
Lansoprazole is a proton pump inhibitor which powerfully suppresses gastric acid production and is widely prescribed for chronic use in gastroesophageal reflux disease. view more (2009-05-14)
Is esomeprazole the best choice for reflux esophagitis patients?
In patients with gastroesophageal reflux disease (GERD), esomeprazole, has demonstrated pharmacological and clinical benefits beyond those seen with the other proton pump inhibitors( PPIs ). view more (2009-03-03)
Takeda's investigational PPI TAK-390MR demonstrated higher healing rates compared to lansoprazole
Combined results from two Phase 3 studies presented at the American College of Gastroenterology Annual Scientific Meeting (ACG) in Orlando, Fla., demonstrated that TAK-390MR resulted in higher healing rates than lansoprazole among patients with more severe grades of erosive esophagitis (EE). view more (2008-10-07)
Common antacids could help keep gingivitis at bay
Chemicals commonly used to treat heartburn also display fighting power against the oral bacteria linked with gum disease, according to researchers at the University of Rochester Medical Center and Göteborg University in Sweden. view more (2006-11-03)
Commonly used ulcer drugs may offer treatment potential in Alzheimer's disease
In a new study, published in the May issue of Elsevier's Experimental Neurology, scientists at the University of British Columbia have discovered that drugs commonly used to treat ulcers have significant neuroprotective properties, which appear to be enhanced when used in combination with ibuprofen, a widely used anti-inflammatory drug. view more (2009-04-22)
Study shows benefits of anti-clotting medications reduced by common heartburn drugs
The anti-clotting action of the medication clopidogrel (Plavix) can be compromised by common drugs for the treatment of heartburn and ulcers resulting in a roughly 50% increase in the combined risk of hospitalization for heart attack, stroke and other serious cardiovascular illnesses. view more (2009-05-07)
What is the best strategy for treating Helicobacter pylori?
The most popular treatment for H pylori is triple therapy but resistance to Clarithromycin is reducing its effectiveness. view more (2008-09-24)
GASTRIC REFLUX COULD BE TEMPERED BY H PYLORI ERADICATION
Eradication of a bacterium present in the stomach could reduce the frequency of a common gastric disorder characterised by heartburn and chest pain, conclude authors of a study in this week's issue of THE LANCET. There is little information on the effects of Helicobacter pylori eradication in patients with a primary diagnosis of gastro-oesophageal... view more... (2001-05-31)
Proton pump inhibitors increase risk of heart attacks for patients on common cardiac drug
Patients taking the common cardiac drug clopidogrel following a heart attack are at a significantly higher risk of a recurrence if they are also taking widely used acid-lowering medications called proton pump inhibitors, a new study published online in CMAJ has found (http://www.cmaj.ca/cgi/rapidpdf/cmaj.082001). view more (2009-01-29)
Gut Reactions in Europe and US
Heartburn disease: A story of sleep, sex and suffering 22 May 2001 – Mölndal, Sweden – Eating, sleeping, sport and sex - activities that are supposed to be part of life’s pleasures are for a large group of people, being disrupted on a daily basis by an unlikely culprit – heartburn. More than 50 million Europeans... view more... (2001-05-22)
|
|
|
|
Sort By:
Page Views | Date |
|
